RNA-U4: A Potential Drug Target and Biomarker (G106481176)

Target Name: RNU4-14P

NCBI ID: G106481176

RNU4-14P

Other Name(s): RNA, U4 small nuclear 14, pseudogene

RNA-U4: A Potential Drug Target and Biomarker

RNA, U4 small nuclear 14 (RNA-U4), also known as pseudogene, is a non-coding RNA molecule that is found in all living organisms. It is a small RNA molecule, with a length of approximately 20-25 nucleotides. RNA-U4 is one of the most abundant pseudogenes in the human genome, and it is expressed in various cell types.

RNA-U4 has been identified as a potential drug target and biomarker. The RNA-U4 gene has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. RNA-U4 has also been shown to be involved in the development and progression of various diseases, including cancer.

One of the key features of RNA-U4 is its role in cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells in the body. When an organism experiences an apoptosis, RNA-U4 has been shown to play a role in the regulation of cell death, by activating the apoptosis-associated protein (AP-1).

RNA-U4 has also been shown to be involved in the regulation of cell cycle progression. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. RNA-U4 has been shown to play a role in regulating the length of the cell cycle, by preventing the rapid cycling of RNA molecules that can disrupt the cell cycle.

In addition to its role in cell apoptosis and cell cycle regulation, RNA-U4 has also been shown to play a role in transcriptional regulation. RNA-U4 has been shown to act as a negative regulator of the gene for the tumor suppressor protein p53. This means that when RNA-U4 is present in the cell, it can prevent the activation of the p53 gene, which is responsible for preventing the formation of tumors.

RNA-U4 has also been shown to play a role in the development of cancer. Studies have shown that RNA-U4 is often expressed in various types of cancer, and that it can contribute to the development and progression of these diseases. RNA-U4 has been shown to promote the growth and survival of cancer cells, and it has also been shown to inhibit the inhibition of cell growth by p53.

In conclusion, RNA-U4 is a small RNA molecule that has been identified as a potential drug target and biomarker. Its role in cell apoptosis, cell cycle regulation, and transcriptional regulation, as well as its involvement in the development and progression of cancer make it an attractive target for further research. Further studies are needed to fully understand the role of RNA-U4 in these processes and to determine its potential as a drug.

Protein Name: RNA, U4 Small Nuclear 14, Pseudogene

The "RNU4-14P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4-14P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets